News Release Details
News Release Details
Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index
"Canine Cancer: Take C.H.A.R.G.E." (Canine Health And ReGistry Exchange) Based on Nationwide
Initial Data from
Take C.H.A.R.G.E. Scientific Advisory
Join us TODAY for Special NYC Media Event and Performance to Celebrate the Launch of Take C.H.A.R.G.E. on National Canine Cancer Awareness Day
The Gallup survey, conducted in
"We established Take C.H.A.R.G.E. to fill a major research gap among the veterinary community and dog owners in
Other key findings from the Gallup survey include:
- More than 8 in 10 dog owners favored the creation of a canine cancer registry to better understand the disease and advance treatments
- After mixed-breed dogs, the 10 most represented breeds in the survey were: 1) Labrador, 2) Chihuahua, 3) Pitbull, 4) Golden Retriever, 5) German Shepherd, 6) Yorkshire, 7) Dachshund, 8) Boxer, 9) Beagle, and 10)
- 68 percent decided not to treat their dog for cancer due to the age of their dog (54 percent), treatment cost (39 percent), treatment side effects (38 percent), or other reasons
- Across all dog owners, the vast majority (92 percent) said they did not have pet insurance at the time of diagnosis
- Nearly 3 in 4 dog parents who experienced canine cancer in the past 10 years were satisfied or very satisfied with their overall experience during treatment, even though only 39 percent reported that their dog was actually cured or went into remission
- While a high proportion of dog owners (46 percent) ‘strongly agreed' that their dog received high quality cancer care, only 30 percent strongly agreed that they knew what to expect during their dog's cancer treatment
- When asked to imagine how difficult it would be for members of their household to manage various chemotherapy-related side effects, the percent of all dog owners rating them as difficult or very difficult were: pain (60 percent), urinary incontinence (43 percent), diarrhea (41 percent), vomiting/nausea (39 percent), decreased appetite (20 percent), and fatigue/lethargy/lack of energy (19 percent)
- Dealing with canine cancer has a major impact on dog owners' well-being, including depression, anxiety, lack of sleep, and missing work or other obligations; for example, 63 percent of respondents reported feeling a lot of stress and 58 percent reported feeling down and depressed a lot during their dog's cancer
- Dog owners' ability to manage their dog's side effects from cancer treatment, such as pain, urinary incontinence, and diarrhea, is the best predictor of key well-being outcomes of the pet owner
- However, many dog parents find managing treatment side effects especially challenging:
- 92 percent of dog owners with no canine cancer experience and 65 percent of those with canine cancer experience said they knew little or nothing about side effects
- Only 22 percent ‘strongly agreed' that they have been able to manage their dog's cancer treatment side effects well, and only 29 percent have a clear understanding of potential side effects of treatment
- Having a veterinarian who cares about a dog's comfort, high quality of care, and thorough explanation of treatment options were most critical to overall treatment satisfaction, whereas management of side effects was the most important factor in determining the negative impact canine cancer has on dog parents' well-being
The complete results of the Take C.H.A.R.G.E. Gallup survey of pet owners can be found here.
Canine Cancer Care Index
In addition to assessing canine cancer incidence and prevalence, and dog owners' perceptions, emotions and experiences related to canine cancer, Gallup used data from the survey to calculate a Canine Cancer Care Index that reflects three dimensions related to canine cancer care: knowledge, quality of care, and canine comfort. Ranging from 0 (the worst possible score) to 100 (the best possible score), the Index will help assess whether canine cancer care experiences are improving, worsening, or staying the same for dog owners and their dogs over time. Gallup determined that the baseline for the Canine Cancer Care Index is 80.5 or a B-, indicating a clear need for improvement.
"Protecting dogs from cancer begins with knowing its impact by breed, type, age, gender, and location," said Take C.H.A.R.G.E.
The Take C.H.A.R.G.E.
"The heart of any cancer registry is its cancer coding system," said
The Take C.H.A.R.G.E.
Craig Clifford, DVM, MS, DACVIM (Oncology), SAB Co-chair. Director of Blue Pearl Science and Medical Oncologist at BluePearl Pet Hospitalin Malvern, PA.
Theresa (Terry) W. Fossum, DVM, MS, PhD, Diplomate ACVS, SAB Co-chair. CEO and Co-founder of Dr. Fossum'sPet Care and CEO of Epic Veterinary Specialists.
Susan Ettinger, DVM, DACVIM (Oncology), also known as Dr Sue Cancer Vet®. Practicing veterinary cancer specialist, co-founder and Chief Medical Officer of Fidu, a teleconsulting company for veterinarians.
Trina Hazzah, DVM, DACVIM (Oncology), CVCH. President and co-founder of the Veterinary Cannabis Society, the first US-based non-profit, 501(c)(3) organization building awareness of cannabis as medicine for pets.
Chad M. Johannes, DVM, DACVIM (SAIM, Oncology). Associate Professor, Colorado State University, ACVIM Oncology Specialty President Elect.
Doug Thamm, V.M.D., Diplomate ACVIM (Oncology). Barbara Cox Anthony Professorof Oncology at Colorado State Universityand Director of Clinical Research for the Flint Animal Cancer Center.
David Vail, DVM, MS, DACVIM (Oncology). Professor of Oncology, Barbara A. Suran Chairin Comparative Oncology, Director of the Barbara A. Suran Comparative Oncology Research Institute, University of Wisconsin.
Rachel Venable, DVM, MS, DACVIM (Oncology). Owner, Pet Cancer Care Consulting, Arizona.
Take C.H.A.R.G.E. Website
Data from the Registry will be accessible to the public via an interactive, easy-to-use dashboard on the Take C.H.A.R.G.E. website, with open access for clinical practitioners and academia to all canine cancer medical record data for research purposes. The Registry will continue to grow as veterinary clinics and pet owners upload medical records of dogs with cancer at no cost to the clinic or pet owner. The data is de-identified, anonymized, and protected following General Data Protection Regulation (GDPR) guidelines to ensure participant information privacy.
Take C.H.A.R.G.E. will also focus on raising awareness of canine cancer by promoting the first annual National Canine Cancer Awareness Day on
Take C.H.A.R.G.E. Launch Event
Dog owners and members of the veterinary community are encouraged to visit TakeChargeRegistry.com for more information, including how to upload canine cancer medical records and how clinics can participate in the Registry. The public and media also are invited to a special event and performance by multiple
For more information about Jaguar, please visit https://jaguar.health. For more information about
Ivee (Intelligent Veterinary Enhanced Experience), is an animal health data-focused software company and is a product of
Certain statements in this press release constitute "forward-looking statements." These include statements regarding
TakeCharge is a registered trademark of
2Pinello K, Baldassarre V, Steiger K, et al. Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2. Cancers (